X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (76) 76
nasopharyngitis - chemically induced (68) 68
female (62) 62
male (62) 62
index medicus (53) 53
middle aged (53) 53
adult (49) 49
treatment outcome (45) 45
double-blind method (33) 33
aged (26) 26
headache - chemically induced (26) 26
double-blind (18) 18
severity of illness index (17) 17
therapy (16) 16
dermatology (15) 15
care and treatment (13) 13
efficacy (13) 13
clinical trials (12) 12
respiratory tract infections - chemically induced (12) 12
analysis (11) 11
antibodies, monoclonal - adverse effects (11) 11
drug administration schedule (11) 11
drug therapy, combination (11) 11
psoriasis - drug therapy (11) 11
safety (11) 11
antibodies, monoclonal - therapeutic use (10) 10
japan (10) 10
nausea - chemically induced (10) 10
adolescent (9) 9
patients (9) 9
diarrhea - chemically induced (8) 8
endocrinology & metabolism (8) 8
management (8) 8
monoclonal antibodies (8) 8
quality of life (8) 8
quality-of-life (8) 8
rheumatology (8) 8
abridged index medicus (7) 7
clinical neurology (7) 7
diabetes mellitus, type 2 - drug therapy (7) 7
dose-response relationship, drug (7) 7
drug therapy (7) 7
young adult (7) 7
antibodies, monoclonal - administration & dosage (6) 6
diabetes (6) 6
follow-up studies (6) 6
injections, subcutaneous (6) 6
original (6) 6
psoriasis (6) 6
antirheumatic agents - therapeutic use (5) 5
arthritis (5) 5
arthritis, rheumatoid - drug therapy (5) 5
child (5) 5
edema - chemically induced (5) 5
etanercept (5) 5
fatigue - chemically induced (5) 5
health aspects (5) 5
hypoglycemia - chemically induced (5) 5
hypoglycemic agents - administration & dosage (5) 5
medicine, general & internal (5) 5
monotherapy (5) 5
nasopharyngitis - drug therapy (5) 5
nasopharyngitis - epidemiology (5) 5
original article (5) 5
plaque psoriasis (5) 5
psychiatry (5) 5
research (5) 5
research article (5) 5
rhinopharyngitis (5) 5
time factors (5) 5
tolerability (5) 5
type 2 diabetes (5) 5
adalimumab (4) 4
animals (4) 4
antibodies, monoclonal, humanized - adverse effects (4) 4
asian continental ancestry group (4) 4
child, preschool (4) 4
clinical trial (4) 4
diabetes mellitus, type 2 - blood (4) 4
epidemiology (4) 4
glycated hemoglobin a - metabolism (4) 4
hypoglycemic agents - adverse effects (4) 4
incidence (4) 4
infant (4) 4
inflammation (4) 4
internal medicine (4) 4
longitudinal studies (4) 4
medical research (4) 4
medicine, experimental (4) 4
metformin (4) 4
methotrexate - therapeutic use (4) 4
moderate (4) 4
oncology (4) 4
open-label (4) 4
original articles (4) 4
pharmacology & pharmacy (4) 4
pruritus (4) 4
randomized controlled trials as topic (4) 4
rheumatoid arthritis (4) 4
trial (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (68) 68
Russian (4) 4
Chinese (1) 1
Croatian (1) 1
French (1) 1
German (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2017, Volume 77, Issue 2, pp. 310 - 317.e1
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 07/2018, Volume 32, Issue 7, pp. 339 - 343
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 12/2016, Volume 118, Issue 12, pp. 1805 - 1811
Previous individual trials of alirocumab (a PCSK9 monoclonal antibody) showed significant low-density lipoprotein cholesterol reductions with overall... 
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | METAANALYSIS | EFFICACY | REDUCING LIPIDS | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | CARDIOVASCULAR-RISK PATIENTS | OUTCOMES | 9 SERINE-PROTEASE | EZETIMIBE | ATORVASTATIN | Back Pain - chemically induced | Myocardial Infarction - epidemiology | Humans | Middle Aged | Nasopharyngitis - chemically induced | Antibodies, Monoclonal - adverse effects | Coronary Disease - epidemiology | Hypercholesterolemia - drug therapy | Diabetes Mellitus, Type 2 - epidemiology | Clinical Trials, Phase III as Topic | Urinary Tract Infections - chemically induced | Respiratory Tract Infections - chemically induced | Stroke - epidemiology | Pruritus - chemically induced | Hypercholesterolemia - epidemiology | Acute Coronary Syndrome - epidemiology | Comorbidity | Ezetimibe - adverse effects | Angina, Unstable - epidemiology | Influenza, Human - chemically induced | Anticholesteremic Agents - adverse effects | Randomized Controlled Trials as Topic | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged | Clinical Trials, Phase II as Topic | Stroke (Disease) | Medical colleges | Analysis | Low density lipoproteins | Atherosclerosis | Monoclonal antibodies | Health aspects | Coronary heart disease | Antilipemic agents | Studies | Confidence intervals | FDA approval | Diabetes | Pruritus | Drug dosages | Patients
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 24, pp. 2335 - 2348
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 2017, Volume 56, Issue 11, pp. 1993 - 2003
Journal Article
Journal of Affective Disorders, ISSN 0165-0327, 2008, Volume 109, Issue 3, pp. 251 - 263
Journal Article
Journal Article
Journal Article